![]() OxThera OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate. | ||
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Austin, US HQ Ames, US | Locations Stockholm, SE HQ Knoxville, US |
Employees | Employees 333% increase | Employees 7 |
Financial | ||
Revenue (est.) | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) kr11m (FY, 2015) |
Net income | Net income ($34m) (FY, 2023) | Net income (kr37.8m) (FY, 2015) |

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
View company